AI-driven MRI analysis complements Amyloid PET in detecting ARIA during Alzheimer's treatment.
Key Details
- 1Color overlay image shows both Amyloid PET and AI-based quantitative MRI results in a single patient.
- 2Case involves a patient with Alzheimer's disease receiving anti-amyloid therapy.
- 3Patient developed amyloid-related imaging abnormalities (ARIA), requiring imaging surveillance.
- 4AI algorithms were used for quantitative MRI analysis to help monitor ARIA changes.
Why It Matters
The integration of AI-based MRI quantification with PET imaging offers an enhanced approach for timely ARIA detection in Alzheimer's patients on anti-amyloid therapies, potentially improving patient safety. Such multimodality AI-driven methods can optimize radiology workflows and diagnostic accuracy in neurodegenerative disease management.
Source
AuntMinnie
Related News
•AuntMinnie
Radiomics Features Vary Between Manual and AI-Driven Segmentations
DL-based segmentations on CT and MRI show limited agreement and bias compared to manual segmentations, affecting radiomics model reliability.
•AuntMinnie
HPI Rebuts AI's Supposed Impact on Radiology Workforce Shortage
Harvey L. Neiman HPI challenges recent claims that AI has lessened the radiology workforce burden, citing evidence of rising workloads and imaging volumes.
•Radiology Business
AI Matches Radiologists in Prostate MRI Cancer Detection in Global Study
A global study finds AI performs comparably to radiologists in detecting prostate cancer on MRI.